Fairness in cost‐benefit analysis: A methodology for health technology assessment
Anne-Laure Samson,
Erik Schokkaert,
Clémence Thébaut,
Brigitte Dormont,
Marc Fleurbaey,
Stéphane Luchini and
Carine Van de Voorde
Health Economics, 2018, vol. 27, issue 1, 102-114
Abstract:
We evaluate the introduction of various forms of antihypertensive treatments in France with a distribution‐sensitive cost‐benefit analysis. Compared to traditional cost‐benefit analysis, we implement distributional weighting based on equivalent incomes, a new concept of individual well‐being that does respect individual preferences but is not subjectively welfarist. Individual preferences are estimated on the basis of a contingent valuation question, introduced into a representative survey of the French population. Compared to traditional cost‐effectiveness analysis in health technology assessment, we show that it is feasible to go beyond a narrow evaluation of health outcomes while still fully exploiting the sophistication of medical information. Sensitivity analysis illustrates the relevancy of this richer welfare framework, the importance of the distinction between an ex ante and an ex post approach, and the need to consider distributional effects in a broader institutional setting.
Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (8)
Downloads: (external link)
https://doi.org/10.1002/hec.3515
Related works:
Working Paper: Fairness in cost-benefit analysis: A methodology for health technology assessment (2018)
Working Paper: Fairness in cost-benefit analysis: A methodology for health technology assessment (2018)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:27:y:2018:i:1:p:102-114
Access Statistics for this article
Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones
More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().